Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1078 | 973 | 1259 | 994 | 1428 | 2032 |
Fund Return | 7.84% | -2.71% | 25.94% | -0.2% | 7.39% | 7.35% |
Place in category | 179 | 369 | 145 | 105 | 69 | 39 |
% in Category | 44 | 89 | 39 | 31 | 25 | 21 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 592.67B | 20.96 | 9.07 | 12.99 | ||
Fidelity Contrafund | 128.94B | 30.86 | 9.80 | 15.03 | ||
Fidelity Contrafund K | 128.94B | 30.89 | 9.88 | 15.12 | ||
Fidelity Total Market Index Instl b | 100.61B | 19.75 | 7.53 | 12.38 | ||
Fidelity Blue Chip Growth | 62.16B | 28.77 | 6.99 | 17.42 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Funds Europacific Growth R | 63.79B | 8.41 | -1.94 | 5.79 | ||
Vanguard International Growth Adm | 38.05B | 12.48 | -5.73 | 8.62 | ||
American Funds Europacific Growth A | 19.46B | 8.10 | -2.30 | 5.41 | ||
American Funds Europacific Growth F | 19.13B | 8.33 | -2.04 | 5.67 | ||
WCM Focused International Growth I | 18B | 11.25 | -2.61 | 9.48 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 3.35 | 618.80 | +0.37% | |
Novo Nordisk B | DK0062498333 | 2.94 | 730.4 | -1.04% | |
SAP | DE0007164600 | 2.72 | 222.500 | +0.86% | |
AstraZeneca | GB0009895292 | 2.26 | 10,008.0 | +0.39% | |
Hitachi | JP3788600009 | 2.20 | 3,750.0 | -1.73% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review